Introduction
The association of osteopetrosis with renal tubular acidosis was first noticed by three separate groups (Guibaud et al., 1972; Sly et al., 1972; Vainsel et al., 1972) . These patients were somewhat less affected than those with 'classic' or 'malignant' autosomal recessive osteopetrosis, which routinely caused compressive neuropathies, hypocalcaemia with seizures and pancytopenia (Loria-Cortes et al., 1977; Stark and Savarirayan, 2009) , and somewhat more affected than patients with autosomal dominant osteopetrosis (Bollerslev et al., 1987; Stark and Savarirayan, 2009 ). In 1980, American (Whyte et al., 1980) and Saudi Arabian (Ohlsson et al., 1980) families with this carbonic anhydrase type II deficiency syndrome (CADS; autosomal recessive osteopetrosis type 3; OPTB3; MIM #259730) were also described to have brain calcifications. Carbonic anhydrase type II deficiency in erythrocytes of patients was identified, in an American family, as a marker for the primary defect of the syndrome (Sly et al., 1983) . The gene for carbonic anhydrase type II (CA2) was mapped to chromosome 8q22 (Venta et al., 1983; Nakai et al., 1987) within a gene cluster also containing genes for carbonic anhydrase types I and III. It is 20 kb long and contains seven exons.
Carbonic anhydrase type II is a cytoplasmic enzyme, which is the most widespread of the 14 known human carbonic anhydrase isoenzymes (Winum et al., 2003; Shah et al., 2004) and has the highest catalytic activity (Baird et al., 1997) for physiological functions including electrolyte and water balance; pH homeostasis; CO 2 and HCO 3 transport; and production of aqueous humor, cerebrospinal fluid, gastric acidity and pancreatic secretions. It also assists in metabolic pathways such as gluconeogenesis, lipogenesis, ureagenesis and bone resorption and calcification (Sly et al., 1991; Sly and Hu, 1995; McMurtrie et al., 2004; Pushkin et al., 2004) . CADS is the only known symptomatic inherited deficiency of a carbonic anhydrase, and to date almost all patients (Borthwick et al., 2003) with osteopetrosis and renal tubular acidosis have had carbonic anhydrase type II deficiency. Many also have reduced vision and some have decreased hearing (Zakzouk et al., 1995) , possibly due to cranial nerve compression within narrowed bony foramina (Ohlsson et al., 1980) . Other features of the disease include short stature, a large cranial vault, multiple skeletal fractures, developmental delay and cognitive defects varying from mild learning disabilities to severe mental retardation, anaemia, splenomegaly and secondary erythropoiesis. These have all been described in Arabic patients with the syndrome from Kuwait (Abdel-Al et al., 1994) and Saudi Arabia (Zakzouk et al., 1995; Awad et al., 2002) . The metabolic derangement may be partially treated with bicarbonate (Nagai et al., 1997) , bone marrow transplantation (McMahon et al., 2001) or possibly gene therapy (Lai et al., 1998) .
Nearly all patients of Arabic descent have a splice junction mutation in CA2 (297 + 1 G4A) at the 5 0 -end of intron 2 (Fathallah et al., 1994) , now known as the Arabic mutation. Mental retardation is reported to be almost universal with this mutation (Bejaoui et al., 1991) , although fractures may be less common (Strisciuglio et al., 1990; Hu et al., 1992; Fathallah et al., 1994) . Patients with the Arabic mutation from the Middle East and the Maghreb constitute 470% of reported cases (Whyte, 1993; Fathallah et al., 1997) . This striking geographical distribution is probably the result of an increased frequency of this CA2 allele in Arab populations (Tashian et al., 1984; Strisciuglio et al., 1990) , the historically well-documented migration of people from the Arabian Peninsula to the Maghreb between the 8th and 10th centuries (Fathallah et al., 1997) , and frequent consanguinity (Salih, 2010) . We had the opportunity to evaluate the neurological, ophthalmological, neuro-ophthalmological and neuroradiological features of 23 patients with the most common CA2 mutation over a relatively prolonged period of time. These individuals highlight the variability of the disorder and shed light on the clinical course of the syndrome in an era when partial treatment is available.
Materials and methods
Individuals from 10 unrelated Saudi Arabian families signed informed consent for a study approved by the institutional review board. This study adhered to the tenants of the Declaration of Helsinki. Most patients had been followed for a period of years in one of the King Saud University hospitals; in addition, all patients were examined by a neurologist, an ophthalmologist and a neuro-ophthalmologist to document clinical status at the time of enrolment. Every individual had osteopetrosis on skeletal radiography. All individuals were also evaluated for renal tubular acidosis defined at least by a metabolic acidosis in the absence of obvious renal insufficiency. Biochemical assessment also included venous blood gases for determination of pH and HCO 3 levels, urine analysis and urine pH when patients were acidotic.
Ophthalmological examinations in this group of patients with CADS were occasionally limited because many of the patients were young and had some degree of mental retardation. Snellen acuities were converted to logMAR units for statistical analysis. All individuals had a basic assessment of cognitive function, and three from Family B (Fig. 1) had formal intelligence testing performed using the Stanford Binet test. Most patients received neuroimaging (brain CT and/or 1.5 or 3 T MRI) at the time of enrolment or within the previous 5 years, and all studies were reviewed by a neuroradiologist (I.A.A.).
Optic canal size and internal auditory canal size were measured at the minimal apparent diameter on available images.
Peripheral blood (5 ml) was collected in EDTA tubes from all participating patients and family members. DNA was extracted using the Illustra TM Blood GenomicPrep Mini Spin Kit from GE Healthcare and stored at À20 C in aliquots until required. Polymerase chain reaction amplification of seven exons of the CA2 coding region and exon-intron boundaries were performed. Amplified fragments were sequenced in both directions using the M13 forward and reverse primers and the BigDye Õ Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). Fragments were then run on the 3130 Â l Genetic Analyser (Applied Biosystems) according to the manufacturer protocol. All the sequenced fragments were analysed utilizing SeqScape software v2.6 (Applied Biosystems). 
Results
We evaluated 23 individuals (Table 1 ; 10 males, 13 females; ages at final examination: 2-29 years) from 10 unrelated Saudi Arabian families (Fig. 1 ). Patients were followed at King Saud University hospitals for as long as 12.5 years. Nine patients had their initial diagnosis and maintained their metabolic follow-up at a regional hospital. One of these (Patient 12, Table 1 ) was diagnosed at birth (Suliman et al., 2010) . Patients 16 and 19 (Table 1) , who presented with floppy infant syndrome, were diagnosed at the Security Forces Hospital, Riyadh and followed-up for 14 and 15 years, respectively, by one of the authors (M.A.S.). The presence of CADS was confirmed in every patient by the presence of osteopetrosis on radiographic bone survey and renal tubular acidosis with metabolic acidosis associated with persistently positive urine anion gap without renal failure. All patient's urinary pH was persistently 45.5, indicating distal renal tubular acidosis. An associated proximal renal tubular acidosis, in addition to the distal renal tubular acidosis, was confirmed in three patients (Family B, Fig. 1 ), but this could not be documented in other families because of erratic compliance with bicarbonate treatment in some and with follow-up investigations in others. None had extramedullary haematopoiesis Awad et al., 2002) . All patients were treated with bicarbonate and Na + K citrate from the time of diagnosis with partial control of acidosis. All families were consanguineous, and none of the enrolled families were related to each other. Direct sequencing of the CA2 gene in all 23 affected individuals confirmed the presence of a splice site base transition from G to A at the 5 0 -end of intron 2, also known as the Arabic mutation ( Fig. 2 ; Hu et al., 1992) , which causes intron 2 retention and introduces 48 cryptic codons before transcription hits a premature stop codon (Fig. 3) . Parents (20 individuals) were always heterozygous for this mutation, while tested unaffected siblings (15 individuals) were either heterozygous or had no CA2 mutation. Mutation analysis revealed the presence of a splice junction mutation at the end of intron 2, also known as the Arabic mutation, in all patients. The sequence output demonstrates the normal sequence (A), heterozygosity in three sisters and both parents of Family B (B) and homozygosity for the three affected individuals in Family B (C). Each individual was the product of a normal pregnancy and delivery. Many were recorded to have infantile hypotonia and failure to thrive during infancy (Table 2) , and when older, generally disproportionate large cranial vault and short stature. None was dysmorphic, although almost all had a broad head with prominent forehead, a long bulbous nose, a relatively thin upper lip and abnormal teeth, as previously described in CADS (Hu et al., 1992; Awad et al., 2002; Suliman et al., 2010) (Fig. 4) . Motor milestones were delayed, with the typical individual beginning to sit between eight and 12 months and to walk after 2 years of age. Speech development was routinely delayed until after the age of 2 years, and gait generally remained unsteady beyond the age of 3 years. The spectrum of cognitive disturbance was broad, with eight patients having grossly normal cognitive function, 13 having mild-to-moderate mental retardation and two being severely mentally retarded. No patient had seizures. Motor examinations were also somewhat variable, documenting normal tone, power and deep tendon reflexes without gross ataxia or spasticity in most individuals. Patient 9 had a history of hypokalemic periodic paralysis (Whyte et al., 1980; Al-Ibrahim et al., 2003) , while Patient 19 had proximal weakness and Patient 22 had brisk deep tendon reflexes. Patients 15 and 21 had severe mental retardation with severe motor delay and spastic quadriparesis.
General ophthalmological examinations revealed normal lids and anterior globes in all with normal intraocular pressures in all tested patients. No patient was proptotic, and Hertel exophthalmometry (when patients were able to cooperate) was normal bilaterally. No patient had a history of chronic tearing, and the dye disappearance test was normal in all patients, implying an intact lacrimal drainage system bilaterally. No patient had a history of orbital cellulitis. Retinae appeared normal in all and electroretinograms were normal in eight affected individuals from the five families.
Of the 46 eyes in our affected individuals, 23 had no evidence of optic atrophy (Table 3) , 21 of whom had grossly normal vision, while Patient 14 had refractive amblyopia oculus uterque. The remaining 23 eyes had objective evidence of optic nerve involvement, including optic atrophy in all and an afferent pupillary defect in seven, where optic nerve involvement was unilateral or asymmetric. Visual acuity in the setting of optic nerve disease ranged from 20/60 to light perception with an average visual acuity of $20/200. Three patients had unilateral optic atrophy, while 10 had bilateral optic atrophy. Nine affected individuals were followed for a period of time long enough to potentially detect progressive optic nerve disease (range 0.5-12 years), but no patient had progressive visual loss or progressive optic atrophy documented. Five patients were substantially hyperopic (refraction 4 + 2.0) in one or both eyes, a frequency typical of this ethnic population.
Patients had full extra-ocular motility, except Patient 5 who had a mild limitation of abduction in the left eye for unclear reasons (Table 4) and Patient 14 who had bilateral inferior rectus skew deviations. Patient 3 had oculomotor apraxia associated with bilateral optic nerve disease, moderate motor delay and modest mental retardation, while Patient 22 had slightly slowed saccades. Patient 15 had roving eye movements with extremely poor vision and bilateral severe optic atrophy. Half of all patients were orthotropic in all directions, but the other half had sensory strabismus or (in Patient 13) accommodative esotropia. Seven patients had small-to-moderate amplitude horizontal pendular nystagmus compatible with congenital nystagmus that occurred in six patients in the setting of bilateral optic atrophy and reduced vision. The seventh patient (Patient 14) was a young child with small amplitude congenital nystagmus and what appeared to be normal vision and fundi.
Eighteen patients had neuroimaging studies (Table 5 ). All had thickened skulls compatible with osteopetrosis and small or absent paranasal sinuses. Orbits and intraorbital structures appeared normal except for thickened bone, and internal auditory canals were of normal size. Optic canals, however, were variable in size and were almost always smaller on the side with greater optic nerve disease (Fig. 5A-C) . Severely reduced optic canal size (e.g. Patient 2 oculus sinister) was always associated with very poor vision, while canal size 43 mm was generally associated with normal optic disk appearance. Optic canal size was correlated with logMAR visual acuity (r = À 0.578; P = 0.001) and with degree of optic atrophy (r = À 0.477; P = 0.003).
One patient had no intracranial calcifications (Patient 15), but the remaining patients had calcifications involving the basal ganglia, thalami and/or the grey-white matter junction ( Fig. 5D-G) . Brain calcification was present in a patient as young as 2 years (Patient 23), but absent in a patient as old as 9 years (Patient 15). Calcifications in the basal ganglia and thalami were almost always symmetric, while calcifications at the greywhite matter junction were often asymmetric. Only posterolateral and anteromedial areas of the thalami were involved. At the greywhite matter junction, frontal lobes were involved more often than parietal, which in turn were involved more often than temporal lobes.
Patient 23 had repeat brain CT studies showing no change in intracranial calcification over 1 year, but all the six individuals followed for longer periods had progression of brain calcification. Brain calcifications remained unchanged for 7 years in Patient 7 and then became noticeably denser in some locations in the eighth year. Patients with more-severe cognitive disturbance (e.g. Patients 14, 15, 20 and 21), surprisingly, had less profound brain calcifications than patients with more-minor cognitive problems (e.g. Patients 5, 7, 8 and 23) . In general, basal ganglia and thalami were spared in individuals with more severe mental retardation, although calcification at the grey-white junctions still occurred. Progressive calcification was noted even in individuals with minimal or no cognitive disturbance. Except for areas of calcification, brain parenchyma appeared normal on CT and routine MRI sequences, including diffusion-weighted images.
Discussion
This relatively large series of patients provides the first opportunity in a decade to update the neurological phenotype of CADS (Awad et al., 2002) . All 23 patients included here had homozygous Arabic mutations in the CA2 gene (Fathallah et al., 1994) so that this group had a confirmed genetic diagnosis and was genetically homogeneous for the most frequently encountered CA2 mutation. All patients had careful neurological, neuro-ophthalmological, ophthalmological and neuroradiological evaluations. As a group they were followed clinically and radiologically for several years, permitting observations about potential disease progression. Unlike earlier series of patients with presumed CADS, all of these patients received bicarbonate from childhood, although in general they remained partially acidotic because of incomplete treatment.
More than 70% of all reported patients with CADS have the Arabic mutation, a splice site mutation in intron 2 of CA2 resulting in a cryptic codon sequence followed by a premature stop codon that truncates the resultant complementary DNA (Fig. 3) and completely extinguishes the functional activity of the carbonic anhydrase type II protein (Hu et al., 1992) . All patients in the present series had osteopetrosis of long bones and skull (Ohlsson et al., 1980) , renal tubular acidosis (Nagai et al., 1997) , short stature and craniofacial disproportion with large cranial vault and broad forehead (Awad et al., 2002) . They had no deafness (Zakzouk et al., 1995) , facial palsy, major facial dysmorphism (Awad et al., 2002) or rickets. The degree of long-bone osteopetrosis and the incidence of long-bone fractures were variable between individuals and did not seem to correlate with neurological or ophthalmological features.
It was initially observed that mental retardation was almost universal in CADS (Ohlsson et al., 1980 (Ohlsson et al., , 1986 Whyte et al., 1980) . However, patients in Belgium (Vainsel et al., 1972) and America were reported with mild mental retardation; at least one previous patient had a mutation that truncated CA2 in exon 2 with grossly normal cognitive function (Shah et al., 2004) , and a previous report from Saudi Arabia described 'psychomotor retardation' in only half of their clinically diagnosed patients (Awad et al., 2002) . Cognitive function was variable in the present series, ranging from grossly normal in eight patients to mental retardation that was mild in four patients, moderate in eight and severe in two. Most patients functioned independently in activities of daily living. General neurological history and examinations were unremarkable except that Patient 9 had a history of hypokalemic periodic paralysis during early childhood that was probably secondary to electrolyte imbalance (Whyte et al., 1980; Al-Ibrahim et al., 2003) , while Patient 19 had evidence of modest proximal muscle weakness , and Patient 22 had mild hyper-reflexia. Other exceptions included Patients 15 and 21, both of whom had severe mental retardation accompanied by spastic quadriparesis.
Neurological examinations, therefore, did not explain the cognitive disturbances in these patients. Brain parenchyma also appeared normal on neuroimaging except for calcification. Osteopetrosis did not cause brain compression either because of increasing bone volume or premature suture closure in this series of patients. Brain calcification seemed unlikely to be the cause of cognitive disturbance, since developmental delay and mental retardation associated with CADS became apparent shortly after birth and seemed static, while calcification typically appeared around the age of 2 years and progressed thereafter (Ohlsson et al., 1980 (Ohlsson et al., , 1986 . Furthermore, patients with more severe cognitive disturbance in this series had less profound brain calcifications than patients with less severe cognitive problems. Carbonic anhydrase type II may play a role in a variety of biological processes in the CNS, including possible regulation of ionic balance (Sapirstein et al., 1984) and memory acquisition and recall (Sun and Alkon, 2002) . A number of carbonic anhydrase-related proteins are expressed in the myelin sheath, neural cell body, neurites and astrocytes of foetal and adult brain (Taniuchi et al., 2002; Kida et al., 2006) . Therefore, mutations in CA2 might cause a primary abnormality in neuronal development or defective neuronal functioning because of an abnormal intra-or extracellular micro milieu and/or abnormal neural connectivity developing in utero. Alternatively, brain dysfunction may be in part the physiological sequelae of the ongoing systemic acid-base disturbance of carbonic anhydrase type II deficiency. It is also possible that infantile acidosis when diagnosed too late or treated inadequately might contribute to long-term moderate cognitive dysfunction. Finally, all of these mechanisms may potentially interact to a greater or lesser extent in different individuals with CADS.
General ophthalmological examinations were normal in all of these patients. In particular, intraocular pressures and corneas were normal despite an unequivocal carbonic anhydrase type II functional deficiency, implying that a carbonic anhydrase other than carbonic anhydrase type II may be responsible for a large component of aqueous secretion, just as other carbonic anhydrases are active in the kidney Sly and Hu, 1995; Kida et al., 2006) . All patients had normal retinal examinations, and patients from three families had normal electroretinograms despite poor vision, making a congenital retinopathy a very unlikely cause of reduced vision in CADS (Ohlsson et al., 1986; Cochat et al., 1987; Thompson et al., 1998) , even though carbonic anhydrase type II is expressed relatively highly in Mü ller cells of the retina (Tashian, 1992) .
Twenty-three eyes had objective evidence of optic nerve involvement, including two who were completely blind oculus uterque. The most likely cause of optic nerve disease in patients with CADS is presumed to be a small optic canal resulting from osteopetrosis that causes compression of the optic nerve with primary optic nerve hypoplasia or atrophy being somewhat less likely. Indeed, clinical and radiological data in this group of patients documents a strong statistical correlation between smaller optic canal size and worse visual acuity and between smaller optic canal size and worse objective evidence of optic neuropathy. These data support an association between optic canal size and optic nerve involvement and highlight the possibility that a small optic canal developing during foetal life or infancy in certain individuals due to ongoing osteopetrosis might affect the development of the ipsilateral optic nerve. However, these data do not prove causation, and neither canal size nor visual acuity decreased during careful follow-up, an observation that calls into question the risk/benefit ratio of treatments intended to prevent progressive decrease in canal size such as surgical optic canal decompression (Al-Mefty et al., 1988; Awad et al., 2002) or bone marrow transplantation (McMahon et al., 2001) . These treatments may not be necessary in CADS if visual loss is not progressive. In general, our patients had full ocular motility; however, two patients had mild motility limitations and two others had saccadic abnormalities. Most patients were orthophoric, but six had esotropias and one an exotropia. Seven individuals had small-tomoderate amplitude horizontal pendular congenital nystagmus that typically occurred in the setting of bilateral poor vision associated with optic nerve involvement. Similar ocular motility abnormalities were not reported previously, but they are relatively subtle and may have been overlooked in comparison with more obvious mental retardation and general medical problems. Strabismus and nystagmus can be largely explained by early-onset afferent abnormalities. Nevertheless, it remains possible that CADS may be associated with a brainstem abnormality affecting particularly ocular motility in certain individuals.
Nineteen patients in the present cohort had neuroimaging performed, often several times over a number of years. Every patient studied had osteopetrosis of the skull, always with thickening of orbital bone and underdevelopment of the paranasal sinuses, frontal and sphenoid sinuses being more affected than ethmoid and maxillary sinuses. However, these patients did not have proptosis, and none had a history of orbital cellulitis like other patients with classical or malignant osteopetrosis (Shapiro, 1993 ; Stark and Savarirayan, 2009). Internal auditory canals were normal in size, and hearing was clinically unaffected, unlike a previous report in which 8 of the 21 patients studied had hearing loss (Awad et al., 2002) . It is possible that some patients had a subtle hearing deficit that was not obvious clinically, but the presence of normal internal auditory canals may indicate that this feature was also less apparent in this series.
The mechanism of cerebral calcification remains unclear, in part because there is no neuropathological description of the disorder. Brain calcification sometimes occurs in the setting of damaged brain (Baba et al., 2005) , but brain parenchyma in these patients appeared normal on all neuroimaging studies. Calcification was not present at birth but usually appeared after the second year of life and increased in density and extended throughout childhood (Awad et al., 2002) in the thalami, the putamen and caudate nuclei and grey-white matter junctions of the frontal, parietal and occipital lobes (Jacquemin et al., 1998) . Only posterolateral and anteromedial portions of the thalami were involved, frontal lobes were more involved than parietal or temporal and the posterior fossa was rarely affected. Curiously, calcification in the deep grey matter was not as striking in those with worse mental retardation, while calcification in grey-white junctions was still present.
The distribution of calcification did not correspond well to the reported activity of carbonic anhydrase type II in many oligodendrocytes, a few neurons and astrocytes, choroid plexus epithelium and areas of possible myelin repair (Tashian, 1992; Morris et al., 1994; Kida et al., 2006) . However, calcification had a pattern identical to that seen in hypoparathyroidism and pseudo-hypoparathyroidism (Cumming and Ohlsson, 1985) and seemed asymptomatic, like brain calcifications in these other diagnoses (Appenzeller et al., 2006) . This similarity is obviously an important clue to the aetiology and significance of brain calcification in carbonic anhydrase type II deficiency. In somewhat similar settings (Smeyers-Verbeke et al., 1975; Murphy, 1979) , brain calcification involves an organic matrix of proteins and mucopolysaccharides in arteriolar walls that attracts minerals, including calcium, over time. Nevertheless, it is not yet clear why these disparate abnormalities cause calcification in this particular brain distribution.
Brain calcification remains a cardinal feature of CADS; however, these observations mean that brain calcification cannot be used as an exclusionary diagnostic criterion in younger patients. Osteopetrosis and renal tubular acidosis were always present from infancy in CADS (Whyte, 1993) . Brain parenchymal calcification, the third cardinal feature of the disorder, was variable and at times unapparent, exemplified here by Patient 2, who had no brain calcifications at the age of 9 years. 'Marble brain disease' (Ohlsson et al., 1980) , therefore, is not an ideal term for this disorder, particularly because it sounds very similar to the more common term 'marble bone disease' used appropriately in the setting of isolated osteopetrosis (Stark and Savarirayan, 2009) . The diagnosis in patients reported here was always made because of infantile acidosis and failure to thrive or because of a family history; brain calcifications generally became apparent long after the diagnosis was made and treatment instituted.
Interpretation of the results of this study requires certain qualifications. The number of patients was relatively small, but this nevertheless constitutes one of the largest studies of this uncommon autosomal recessive disorder in terms of both patient and family number. All patients had the Arabic mutation of CA2, but this mutation is the most frequent worldwide and is arguably among the most severe genetically and clinically (Hu et al., 1992) . At this juncture, it is reasonable to assume that the clinical characteristics of carbonic anhydrase type II deficiency due to the Arabic mutation are generalizable to other CA2 mutations. Some components of the evaluation reported here were partially incomplete, most commonly as the result of limited co-operation from young children with some element of mental retardation and from certain families who had to travel a considerable distance for evaluation and testing. Some patients had anomalous results in certain parameters, but this is not unanticipated given the recognized clinical variability of genetic disorders (Bosley et al., 2005 (Bosley et al., , 2006 (Bosley et al., , 2007 , the fact that actions of carbonic anhydrase type II in certain tissues may be augmented by other carbonic anhydrases (Sly et al., 1991; Sly and Hu, 1995) , and the molecular variability of genetic mechanisms (Hu et al., 1994; Tansey et al., 1996) . Almost all of these patients were referred to King Saud University hospitals for tertiary care, so it is possible that an ascertainment bias was present for more severely affected individuals.
The major clinical features of CADS described here are similar to those reported previously. However, the largest recent series of patients with CADS described a somewhat more severe phenotype with more frequent blindness, hearing loss and extramedullary haematopoiesis (Awad et al., 2002) . All patients in the current study were treated from infancy or childhood with bicarbonate, with partial control of systemic pH, and this treatment may have reduced phenotypic severity. Interestingly, siblings from individual families tended to have relatively similar cognitive function. This may be due to unrecognized genetic or epigenetic factors but could also be due to the fact that patients in each family were generally treated with bicarbonate with similar effectiveness. Bicarbonate treatment of CADS, therefore, may constitute a partial success in treatment of this genetic disease, a possibility that calls attention again to the importance of early diagnosis and treatment.
This report contains a number of new observations regarding this unusual autosomal recessive disorder. General neurological exams in these patients were unremarkable except for a few individuals with relatively severe mental retardation who had bilateral upper motoneuron disease. Globes and retinae were normal in every patient. Small optic canals and optic nerve involvement occurred commonly and were unequivocally statistically linked. Ocular motility was frequently not normal. While strabismus and nystagmus were usually explicable by the presence of afferent dysfunction, the possibility remains that CADS is associated at times with a component of brainstem dysfunction affecting ocular motility. Brain calcification was progressive and was noted to have a very specific distribution in the basal ganglia, the thalami, and the grey-white matter junctions. Worse mental retardation was associated with less deep grey matter calcification for unclear reasons.
Carbonic anhydrase type II is barely expressed pre-natally in erythrocytes, the cell type on which the enzymatic diagnosis has routinely been made in adults (Sly et al., 1983 . Therefore, prenatal diagnosis by direct CA2 gene sequencing using DNA obtained from amniocytes or chorionic villus biopsy has obvious advantages (Shah et al., 2004 ). An early diagnosis might permit early treatment of failure to thrive and possibly partial avoidance of mental retardation and other complications. In the Middle East and Northern Africa, physicians should look first for the Arabic mutation because it is by far the most common CA2 mutation in the world and the only one currently identified in this region. Familial recurrences, as tragically observed in this cohort, can be definitively prevented by identification of the causative mutation during pre-implantation genetic screening.
